5 Large-cap Stocks with Highest Dividends

2. Pfizer Inc. (NYSE:PFE) 

Dividend Yield as of March 28: 6.36%

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company’s global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer health care products.

Pfizer Inc. (NYSE:PFE) and Valneva announced on March 23 that their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its key statistical requirement meant to ensure reliability. According to the drugmaker, the key reason for missing the goal was that there were not enough people in the study who contracted Lyme disease to be confident in the results. However, the partners deem the overall results encouraging and now plan ​to move ahead with regulatory submissions.

There is currently no approved vaccine to prevent Lyme disease, which is spread by bites from infected blacklegged ticks. Pfizer’s vaccine ⁠demonstrated 73.2% efficacy starting 28 days after the fourth dose in reducing ​confirmed Lyme disease cases, compared to the placebo. Valneva is estimating the vaccine to achieve peak annual sales of $1 billion.

Annaliesa Anderson, Ph.D., Senior Vice President and Chief Vaccines Officer at Pfizer Inc. (NYSE:PFE), commented:

“Lyme disease can cause potentially serious consequences – where individuals and families face symptoms that can disrupt daily life, work, and long-term health – and there is currently no vaccine available. The efficacy shown in the VALOR study of more than 70% is highly encouraging and creates confidence in the vaccine’s potential to protect against this disease that can be debilitating.”